Sale!

SLC35A3 Gene Arthrogryposis Mental Retardation and Seizures Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “SLC35A3 Gene Arthrogryposis Mental Retardation and Seizures Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SLC35A3 gene. These mutations are associated with a rare but severe genetic disorder characterized by arthrogryposis (joint contractures), intellectual disability, and seizures. The test aims to provide crucial information for the diagnosis, management, and understanding of this complex condition.

The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the SLC35A3 gene. This gene plays a significant role in the development and function of the nervous system, and mutations can lead to the symptoms observed in affected individuals.

With a cost of 4400 AED, the test is an investment in gaining a comprehensive understanding of the genetic factors contributing to the condition. This information can be invaluable for affected families in terms of planning medical care, understanding the risk of recurrence in future pregnancies, and accessing appropriate support and resources. DNA Labs UAE provides this testing service with professionalism and confidentiality, ensuring that patients and their families receive the information and support they need during the diagnostic process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC35A3 Gene Arthrogryposis Mental Retardation and Seizures Genetic Test

Test Name: SLC35A3 Gene Arthrogryposis Mental Retardation and Seizures Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC35A3 Gene Arthrogryposis, Mental Retardation, and Seizures NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC35A3 Gene Arthrogryposis, Mental Retardation, and Seizures NGS Genetic DNA Test gene SLC35A3

Test Details

The SLC35A3 gene is associated with a genetic condition known as Arthrogryposis, Mental Retardation, and Seizures (AMRS). This condition is characterized by multiple joint contractures (arthrogryposis), intellectual disability (mental retardation), and seizures.

NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. This approach allows for the rapid and cost-effective analysis of large gene panels or even the entire exome (all protein-coding genes in the genome).

In the context of AMRS, NGS genetic testing can be used to identify mutations or variants in the SLC35A3 gene. By sequencing this gene, clinicians can determine if there are any alterations in the DNA sequence that may be responsible for the development of the condition.

This type of genetic testing can provide valuable information for diagnosis, prognosis, and genetic counseling for individuals and families affected by AMRS. It can help confirm a suspected diagnosis, guide appropriate medical management, and provide information about the likelihood of passing the condition on to future generations.

Test Name SLC35A3 Gene Arthrogryposis mental retardation and seizures Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC35A3 Gene Arthrogryposis, mental retardation, and seizures NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC35A3 Gene Arthrogryposis, mental retardation, and seizures NGS Genetic DNA Test gene SLC35A3
Test Details

The SLC35A3 gene is associated with a genetic condition known as Arthrogryposis, Mental Retardation, and Seizures (AMRS). This condition is characterized by multiple joint contractures (arthrogryposis), intellectual disability (mental retardation), and seizures.

NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. This approach allows for the rapid and cost-effective analysis of large gene panels or even the entire exome (all protein-coding genes in the genome).

In the context of AMRS, NGS genetic testing can be used to identify mutations or variants in the SLC35A3 gene. By sequencing this gene, clinicians can determine if there are any alterations in the DNA sequence that may be responsible for the development of the condition.

This type of genetic testing can provide valuable information for diagnosis, prognosis, and genetic counseling for individuals and families affected by AMRS. It can help confirm a suspected diagnosis, guide appropriate medical management, and provide information about the likelihood of passing the condition on to future generations.